Dallas Fort Worth Injury Lawyer Blog

October 4, 2013

California DePuy ASR Hip Implant Failure Trial Settled

According to court documents, Johnson & Johnson has agreed to settle a DePuy ASR hip replacement lawsuit, on the eve of trial. The settlement agreement remains confidential.

Johnson & Johnson subsidiary DePuy Orthopaedics has agreed to settle a DePuy ASR hip lawsuit, the first bellwether trial in a California state court consolidation of ASR cases.

This DePuy ASR case that was set to begin later in October in California state court. See my earlier reporting on secret settlement negotiations regarding the DePuy ASR implants. This is overall good news for plaintiffs that the company is beginning to take the failure allegations seriously.

September 30, 2013

Bard, Boston Scientific, Endo Health/AMS Vaginal-Mesh Makers Settlement on the horizon

by Dr. Shezad Malik

As a Texas Vaginal Mesh attorney, and Dallas medical doctor, we are reporting this important potential transvaginal mesh settlement breakthrough. According to sources, C.R. Bard Inc., and other makers of vaginal-mesh implants, are in advanced talks to settle thousands of vaginal mesh product liability lawsuits.

Bard, Endo Health Solutions Inc. the parent of AMS, Boston Scientific Corp., Coloplast and Cook Medical Inc. manufacturers making vaginal mesh devices to treat pelvic organ prolapse (POP) and treat stress urinary incontinence (SUI) in talks about settling all suits.

Johnson & Johnson, which also faces suits over the vaginal mesh devices, isn’t involved in the talks.

September 25, 2013

Bard, Ethicon, Boston Scientific, AMS, Coloplast Vaginal Mesh Litigation

by Dr. Shezad Malik

Transvaginal mesh injury lawsuits are consolidated and coordinated in 6 individual multidistrict litigations (MDLs) established in the federal court system. These injury claims against vaginal mesh manufacturers have now become the largest pending litigation in the U.S.

30,000 Active Mesh Lawsuits and Climbing

There are more than 30,000 complaints filed in U.S. District Courts over injuries with transvaginal mesh and bladder sling products. These medical devices have been used for treatment of pelvic organ prolapse (POP) and female stress urinary incontinence (SUI).

September 25, 2013

Mirena IUD Perforation Injury Lawsuits

by Dr. Shezad Malik

As a Texas Mirena IUD Product Liability attorney, I am providing this timely Mirena litigation update. Mirena IUD product liability lawsuits continues to increase, with 400 complaints being filed in federal and state courts, across the country.

Federal MDL Consolidation

The U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized all lawsuits filed in U.S. District Courts before one judge for coordinated pretrial proceedings.

September 25, 2013

Actos Trial: Takeda Duped Patients, Doctors on Actos Bladder Cancer Risk

by Dr. Shezad Malik

According to the testimony presented in trial, Takeda Pharmaceutical Co. duped patients and doctors about the risks of its Actos diabetes drug and should be held liable for the cancer death of a former U.S. Army translator.

Takeda did not disclose Bladder Cancer Risks

The plaintiff alleged that Japan-based Takeda, failed to provide any warning until 2011 that researchers had linked Actos to bladder cancer. The family of Diep An, filed a wrongful death product liability lawsuit in state court in Baltimore, MD. The plaintiff’s attorney allege that the lack of a warning allowed the company to protect billions in sales of the drug.

September 25, 2013

Bard Avaulta, Ethicon Gynecare Vaginal Mesh for Prolapse Repair

by Dr. Shezad Malik

As a Texas Transvaginal mesh attorney and medical doctor, I am providing details on this latest medical research. According to new published research, transvaginal mesh placement provides no benefits when used for pelvic organ prolapse repair. In a study published in the Obstetrics and Gynecology journal, researchers found that the use of vaginal mesh does not increase good outcome for surgical prolapse repair when compared to more traditional treatments.

Georgetown University researchers halted the study due to the high rate of serious injuries associated with use of vaginal mesh. The study involved 65 women, 33 of whom received vaginal mesh to treat pelvic organ prolapse (POP) and 32 who underwent traditional vaginal prolapse surgery.

The women were followed for three years and the program stopped early because of a 15.6% mesh exposure rate, where the mesh eroded into the vagina.

September 25, 2013

J&J Will Stop Sales of Metal-on-Metal Hip Replacements

by Dr. Shezad Malik

As a Texas Metal on Metal hip attorney and medical doctor I am providing this important update to the folks injured by a defective metal hip implant. According to Johnson & Johnson (JNJ), it will stop selling metal-on-metal and ceramic-on-metal hip replacements because of a lower demand for the devices.This decision announcement was made in May 2013.

Metal liners in the Ultamet Metal-on-Metal Articulation and the Complete Ceramic-on-Metal Acetabular Hip System will no longer be available worldwide after August 31. J&J’s DePuy Orthopaedics unit will stop selling related products through 2014 to simplify and streamline its offerings.

Metal on Metal Hip Replacement Sales

September 17, 2013

Dallas, Texas Vaginal Mesh Attorney Warns About Side Effects

by Dr. Shezad Malik

As a Dallas, Texas Trans Vaginal Mesh attorney, I am highlighting this latest research that is putting another nail in the Mesh coffin. According to new published research, transvaginal mesh placement provides no benefits when used for pelvic organ prolapse repair. In a study published in the Obstetrics and Gynecology journal, researchers found that the use of vaginal mesh does not increase good outcome for surgical prolapse repair when compared to more traditional treatments.

Georgetown University researchers halted the study due to the high rate of serious injuries associated with use of vaginal mesh. The study involved 65 women, 33 of whom received vaginal mesh to treat pelvic organ prolapse (POP) and 32 who underwent traditional vaginal prolapse surgery.

The women were followed for three years and the program stopped early because of a 15.6% mesh exposure rate, where the mesh eroded into the vagina.

September 16, 2013

Bard Avaulta Mesh Cases Beginning to Settle

by Dr. Shezad Malik

According to reports, C.R. Bard Inc., has agreed to settle a one of its Avaulta vaginal-mesh implant lawsuits, which allegedly caused severe urinary problems. This case was set for trial this month in New Jersey.

Bard agreed to pay an undisclosed sum to resolve Melanie Virgil’s claims that Bard’s Avaulta Plus insert caused urinary problems. Virgil’s case had been set for a Sept. 23 trial in state court in Atlantic City.

According to the filings, the 56-year-old woman said she needed three surgeries to address urinary problems created by the insert.

September 15, 2013

Boston Scientific Pelvic Mesh Selected for Bellwether Trials

by Dr. Shezad Malik

The U.S. District Judge presiding over the federal transvaginal mesh litigation has chosen four Boston Scientific cases that will be considered for early bellwether trials, scheduled to start in 2014.

Litigation Continues to Grow

There are more than 22,500 federal lawsuits involving vaginal mesh pelvic repair systems manufactured by different companies. These mesh products have been associated with severe injuries when the device eroded through the vagina.